Medicine
Chlorhexidine 1.2 mg/mL solution
Chlorhexidine 1.2 mg/mL solution is a generic prescription medicine for dental use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Chlorhexidine gluconate oral rinse is supplied as a blue liquid and is…
Key facts
- Active ingredient (INN)
- Chlorhexidine
- Brand
- Sold under the generic name
- Strength
- 1.2 mg/mL
- Dosage form
- Solution
- Route
- Dental
- Packs
- 100 cup, 118 mL, 473 mL and 12 more
- Manufacturers
- Bajaj MedicalAtlantic BiologicalsAmerican Health PackagingRising Pharma HoldingsA2A Integrated PharmaceuticalsBrisk PharmaceuticalsKesin PharmaNuCare Pharmaceuticals,Inc
- Origin register
- US FDA, United States
- Storage
- Chlorhexidine gluconate oral rinse is supplied as a blue liquid and is available as follows: 15 mL unit dose cups: NDC 73141-512-15 Carton containing 100 unit dose cups of 15 mL: NDC 73141-512-50 STORE at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C °F (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A01AB03 Chlorhexidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 November 2021
- Identifiers
- RxCUI 834127DailyMed set ID 27d81483-e58c-593d-e063-6394a90a0db4, 21002357-1780-4a5d-ad54-9936f4a9c031, d44f4e79-e684-a1ef-e053-2995a90a4620 +5NDC 73141-512, 60687-714, 61037-469 +5Application ANDA075561
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 cup, unit-dose in 1 carton / 15 mL in 1 cup, unit-dose | 73141-512-50 | A2A Integrated Pharmaceuticals | 14 January 2025 |
| 118 mL in 1 bottle | 61037-469-02 | Bajaj Medical | 17 November 2021 |
| 473 mL in 1 bottle | 61037-469-03 | Bajaj Medical | 17 November 2021 |
| 1893 mL in 1 jug | 61037-469-05 | Bajaj Medical | 17 November 2021 |
| 15 mL in 1 cup, unit-dose | 61037-469-07 | Bajaj Medical | 17 November 2021 |
| 118 mL in 1 bottle | 73614-203-01 | Brisk Pharmaceuticals | 10 February 2025 |
| 473 mL in 1 bottle | 16571-128-48 | Rising Pharma Holdings | 27 July 2023 |
| 100 cup, unit-dose in 1 box, unit-dose / 15 mL in 1 cup, unit-dose | 16571-128-52 | Rising Pharma Holdings | 1 April 2024 |
| 10 tray in 1 case / 10 cup, unit-dose in 1 tray / 15 mL in 1 cup, unit-dose | 60687-714-16 | American Health Packaging | 20 July 2023 |
| 4 tray in 1 case / 10 cup, unit-dose in 1 tray / 15 mL in 1 cup, unit-dose | 60687-714-64 | American Health Packaging | 14 June 2023 |
| 72 cup, unit-dose in 1 case / 15 mL in 1 cup, unit-dose | 17856-2128-1 | Atlantic Biologicals | 4 August 2026 |
| 72 cup, unit-dose in 1 case / 5 mL in 1 cup, unit-dose | 17856-2128-2 | Atlantic Biologicals | 9 September 2026 |
| 50 cup, unit-dose in 1 case / 30 mL in 1 cup, unit-dose | 17856-2128-3 | Atlantic Biologicals | 9 September 2026 |
| 100 cup, unit-dose in 1 carton / 15 mL in 1 cup, unit-dose | 81033-512-50 | Kesin Pharma | 15 August 2023 |
| 473 mL in 1 bottle | 68071-3630-6 | NuCare Pharmaceuticals,Inc | 17 June 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 17 September 1976 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Chlorhexidine 1.2 mg/mL solution.
Other strengths and forms of Chlorhexidine
Clinical summary
Chlorhexidine is a prescription medicine. It is available as oral rinse, solution and oral liquid for dental and buccal use. MedsAcross supplies Chlorhexidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ChlorhexidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ANTISEPTIC SKIN CLEANSER prescribing information (Xttrium Laboratories) · U.S. National Library of Medicine, DailyMed
Need Chlorhexidine 1.2 mg/mL solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.